ArticleInvestigational new drugs2020

Ibrutinib as a potential therapeutic option for HER2 overexpressing breast cancer - the role of STAT3 and p21.

Chandra Bose Prabaharan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.